Valuation: AstraZeneca PLC

Market Cap 241B 215B 201B 182B 344B 23,233B 346B 2,423B 943B 11,858B 906B 886B 38,115B P/E 2026 *
19.8x
P/E 2027 * 17.3x
Enterprise Value 261B 233B 217B 197B 372B 25,145B 375B 2,622B 1,020B 12,834B 980B 959B 41,252B EV / Sales 2026 *
4.13x
EV / Sales 2027 * 3.78x
Free-Float
96.62%
Yield 2026 *
2.15%
Yield 2027 * 2.28%
1 day-0.89%
1 week-5.83%
Current month-4.20%
1 month-2.02%
3 months-18.62%
6 months-23.19%
Current year-14.69%
1 week 11,716
Extreme 11716
12,518
1 month 11,552
Extreme 11552
12,788
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,090.32
Extreme 8090.32
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap. Importance
9/14/26 Free

Chief Financial Officer

73 0.0000%
9/14/26 Buy

Chairman

2,500 0.0002%
9/14/26 Buy

Chief Executive Officer

60,000 0.0039%
Change 5-day change 1-year change 3-year change Capi.($)
-0.89%-5.83%-7.00%+7.91% 244B
+0.02%-3.52%+36.11%+111.11% 1,019B
-1.21%-6.99%+34.08%+60.96% 617B
+1.12%-0.20%+13.62%+80.24% 464B
-3.30%-6.15%+56.45%+34.69% 356B
+0.93%-1.83%+21.65%+41.43% 333B
+0.12%-4.05%+10.70%+33.53% 267B
-0.01%-3.62%+35.28%+52.02% 218B
-0.08%-4.98%+28.34%+93.61% 179B
-0.78%-2.16%-34.86%-61.18% 166B
Average +0.11%-3.54%+19.44%+45.43% 386.29B
Weighted average by Cap. +0.39%-3.55%+25.78%+62.93%

Financials

2026 *2027 *
Net sales 63.17B 56.35B 52.5B 47.78B 89.97B 6,083B 90.64B 634B 247B 3,105B 237B 232B 9,980B 67.04B 59.81B 55.72B 50.71B 95.49B 6,456B 96.2B 673B 262B 3,295B 252B 246B 10,592B
Net income 12.04B 10.74B 10B 9.1B 17.14B 1,159B 17.27B 121B 47.03B 592B 45.19B 44.21B 1,902B 13.78B 12.29B 11.45B 10.42B 19.62B 1,327B 19.77B 138B 53.83B 677B 51.71B 50.6B 2,177B
Net Debt 19.85B 17.71B 16.5B 15.01B 28.28B 1,912B 28.49B 199B 77.56B 976B 74.52B 72.92B 3,137B 12.08B 10.78B 10.04B 9.14B 17.21B 1,164B 17.34B 121B 47.21B 594B 45.36B 44.38B 1,909B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-10-05 GBX 11,764.00 -0.89% 1,619,067
26-10-02 GBX 11,870.00 -1.35% 1,659,276
26-10-01 GBX 12,032.00 -2.02% 3,717,062
26-09-30 GBX 12,280.00 -1.19% 3,855,860
26-09-29 GBX 12,428.00 -0.51% 2,735,445
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
155.54USD
Average target price
209.82USD
Spread / Average Target
+34.90%

Quarterly revenue - Rate of surprise